Changes in Beneficial Ownership · 4
Waters Corp
WATNYSEEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4.xml
Filing details
- Report period
- 2026-06-30
- Issuer
- WATERS CORP /DE/
- Issuer CIK
- 0001000697
- Trading symbol
- WAT
Reporting owner 1
- Name
- Jiang Wei
- Reporting owner CIK
- 0001867980
- Relationship
- Director
- Address
- 34 MAPLE STREET, MILFORD, MA, 01757
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-06-30 | A · Form 4 | 67.42[F1] | A | 0 | 3,572.75 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur automatically upon the Reporting Person's termination of service as a member of the Issuer's Board of Directors.↩ 1
Signature 1
- Signed
- /s/ Kimberly Larie, attorney-in-fact for Wei Jiang
- Date
- 2026-07-02
Filed exhibits
Company context
Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~15,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide.